About Us

Our mission is to become the key that unlocks nature's full potential for human health, happiness, and well-being.

Our Philosophy

Purity

Purity is a prerequisite to ensure that you receive the purest raw materials free from contaminants and GMO’s just as nature intended.

Non-GMO

Potency

At 4POTENTIA, we capture the power in nature with clean extraction technologies to isolate, concentrate, standardize, and guarantee our actives for meaningful potency and efficacy.

100% Quality Guarantee

Proprietary

4POTENTIA ingredients are unique, novel, proprietary, patented and scientifically validated bringing your finished formulations a competitive edge.

Patented
Clinical Science

Proven

Science is at the heart of 4POTENTIA.  We use ingredients with a strong scientific foundation, backed by clinical studies and produced in cGMP facilities.

cGMP

Our Legacy

25 Years of Excellence & Integrity

11
Patents
8
Human Studies
1999

IN Ingredients Founded

IN Ingredients Founded

2006

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2007

Award - “INSIDER”- Scientific Excellence Winner

Award - “INSIDER”- Scientific Excellence Winner

2007

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2009

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2010

US Patent 7,674,484 B2

US Patent 7,674,484 B2

2011

US Patent 8,002,141 B2

US Patent 8,002,141 B2

2012

US Patent 8,318,221 B2

US Patent 8,318,221 B2

2012

US Patent 8,158,683 B2

US Patent 8,158,683 B2

2013

US Patent 8,445,035 B2

US Patent 8,445,035 B2

2014

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2014

US Patent 8,822,536 B2

US Patent 8,822,536 B2

2016

US Patent 9,278,104 B2

US Patent 9,278,104 B2

2016

Human Study (4Restore™)

Human Study (4Restore™)

2017

Human Study (4Restore™)

Human Study (4Restore™)

2018

US Patent 10,039,798 B2

US Patent 10,039,798 B2

2018

US Patent 10,058,579 B2

US Patent 10,058,579 B2

2018

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2020

US Patent 10,543,241 B2

US Patent 10,543,241 B2

2020

US Patent 10,772,923 B2

US Patent 10,772,923 B2

2022

Human Study (Cinnulin PF®)

Human Study (Cinnulin PF®)

2024

IN-Ingredients becomes 4POTENTIA "A Force of Nature"

IN-Ingredients becomes 4POTENTIA "A Force of Nature"

DrAg
1999
IN Ingredients Founded
2006
Human Study (Cinnulin PF®)
Human study published by Journal of the International Society of Sports Nutrition. (Effects of a Water-Soluble Cinnamon Extract on Body Composition and Features of the Metabolic Syndrome in Pre-diabetic Men and Women)
2007
Award - “INSIDER”- Scientific Excellence Winner
Cinnulin PF® honored as the very first winner of the INSIDER SCIENTIFIC EXECELLENCE AWARD at Supply Side West.
2007
Human Study (Cinnulin PF®)
Human study published by American Society for Reproductive Medicine. (The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study)
2009
Human Study (Cinnulin PF®)
Human study published by the American College of Nutrition. (Antioxidant Effects of Cinnamon Extract)
2010
US Patent 7,674,484 B2
US Patent 7,674,484 B2 granted. (Dietary supplement including He Shou Wu, parasitic loranthus and green tea to promote weight loss)
2011
US Patent 8,002,141 B2
US Patent 8,002,141 B2 granted. (Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport)
2012
US Patent 8,318,221 B2
US Patent 8,318,221 B2 granted. (Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport)
2012
US Patent 8,158,683 B2
US Patent 8,158,683 B2 granted. (Dietary supplements containing extracts of aronia and methods of using same to promote weight loss)
2013
US Patent 8,445,035 B2
US Patent 8,445,035 B2 granted. (Dietary supplements containing extracts of aronia and methods of using same to promote weight loss)
2014
Human Study (Cinnulin PF®)
Human study published by the American Journal of Obstetrics & Gynecology. (Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial)
2014
US Patent 8,822,536 B2
US Patent 8,822,536 B2 granted. (Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in animals)
2016
US Patent 9,278,104 B2
US Patent 9,278,104 B2 granted. (Methods and materials for reducing multiple risk factors associated with the metabolic syndrome)
2016
Human Study (4Restore™)
Human study published by Scientific Research Publishing Inc. (Impact of a dietary supplement containing rosemary and daylily on biochemical markers of cognitive health, sleep quality and related variables in men and women)
2017
Human Study (4Restore™)
Human study published by HSOA Journal of Alternative, Complementary & Integrative Medicine. (Impact of the dietary supplement CLOCK® on BDNF and other biochemical measures related to cognitive function and health in men and women)
2018
US Patent 10,039,798 B2
US Patent 10,039,798 B2 granted. (Extracts of rosemary or hemerocallis fulva and methods of using same to promote circadian rhythm)
2018
US Patent 10,058,579 B2
US Patent 10,058,579 B2 granted. (Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity)
2018
Human Study (Cinnulin PF®)
Human study published by Complementary Therapies in Medicine. (Effect of water-soluble cinnamon extract on electrocardiographic parameters: An analysis of the cinnamon trial)
2020
US Patent 10,543,241 B2
US Patent 10,543,241 B2 granted. (Methods and materials for reducing multiple risk factors associated with the metabolic syndrome)
2020
US Patent 10,772,923 B2
US Patent 10,772,923 B2 granted. (Methods and materials for increasing lean muscle mass)
2022
Human Study (Cinnulin PF®)
Human study published by Sport Mont. (The effect of cinnamon extract on recovery and performance of weightlifting athletes)
2024
IN-Ingredients becomes 4POTENTIA "A Force of Nature"

Leadership Team

Chief Executive Officer

Jade Beutler

Chief Business Officer

John Mai

Need to get in touch?

We’re more than happy to answer your questions.